Bradford Amman

Chief Financial Officer

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

VVOS

CFO

2 calls Latest call 2026-04-15

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Vivos Therapeutics, Inc. (VVOS)	Chief Financial Officer	$267,637	—	—	$390,824	$26,365	$21,952	$705,919
2023	Vivos Therapeutics, Inc. (VVOS)	Chief Financial Officer	$313,575	—	—	—	—	$21,952	$400,040
2022	Vivos Therapeutics, Inc. (VVOS)	Chief Financial Officer	$256,532	—	—	$195,691	$20,858	$19,838	$492,919
2021	Vivos Therapeutics, Inc. (VVOS)	Chief Financial Officer	$230,182	—	—	$805,560	$52,048	$18,302	$1,106,092
2020	Vivos Therapeutics, Inc. (VVOS)	Chief Financial Officer	$181,167	—	—	—	$65,348	$22,423	$268,938
2019	Vivos Therapeutics, Inc. (VVOS)	Chief Financial Officer (principal accounting officer)	$180,000	—	—	$98,727	—	$18,493	$297,220

Earnings-call appearances and filed executive appointments or departures, newest first.